The US Food and Drug Administration (FDA) has granted an emergency use authorization (EUA) for the Janssen COVID-19 Vaccine – Ad26.COV2.S manufactured by Johnson & Johnson subsidiary Janssen Biotech. It…
Humacyte, a clinical-stage biotech platform company, has agreed to merge with blank check company Alpha Healthcare Acquisition Corp. (AHAC), in a deal that values the combined firm at $1.1 billion.…
G1 Therapeutics has bagged approval for Cosela (trilaciclib) from the US Food and Drug Administration (FDA) for reducing bone marrow suppression caused by chemotherapy. Cosela FDA approval is for its…
Targovax, a Norwegian immune-oncology company, said that its lead candidate ONCOS-102 has secured the fast track designation from the US Food and Drug Administration (FDA) for malignant pleural mesothelioma. The…
Boston Scientific, in late January 2021, signed an agreement to take full ownership of mobile cardiac health solutions and services provider Preventice Solutions in a deal that values 100% of…
Sandoz, a division of Swiss pharma giant Novartis, has agreed to acquire GSK’s cephalosporin antibiotics business in a deal worth up to $500 million. The deal gives Sandoz global rights…
Boston Scientific to take full ownership of Preventice Solutions
Boston Scientific, in late January 2021, signed an agreement to take full ownership of mobile cardiac health solutions and services provider Preventice Solutions in a deal that values…
DJO acquires orthopedic implants provider Trilliant Surgical
DJO, a Texas-based medical technologies provider, has acquired Trilliant Surgical, an orthopedic foot and ankle implants provider, for an undisclosed price. The acquisition, which was announced in January…
Philips to acquire medical device integration firm Capsule Technologies for $635m
Dutch health technology company Royal Philips has signed an all-cash deal worth $635 million to acquire Capsule Technologies, a portfolio company of Francisco Partners. Based in Massachusetts, Capsule…
Hillrom to acquire CAM patch developer Bardy Diagnostics for $375m
Chicago-based medical technology company Hillrom is acquiring Bardy Diagnostics (BardyDx), a digital health and ambulatory cardiac monitoring technologies provider, for $375 million. Bardy Diagnostics will also be eligible…
Human tissue developer Humacyte to go public via $1.1bn merger with Alpha Healthcare
Humacyte, a clinical-stage biotech platform company, has agreed to merge with blank check company Alpha…
Sandoz to acquire GSK’s cephalosporin antibiotics business in $500m worth deal
Sandoz, a division of Swiss pharma giant Novartis, has agreed to acquire GSK’s cephalosporin antibiotics…
Thermo Fisher, JW Therapeutics sign CAR-T partnership in China
Thermo Fisher Scientific has signed an agreement with Chinese cell therapy company JW Therapeutics to…
Jazz Pharmaceuticals to acquire Epidiolex developer GW Pharmaceuticals for $7.2bn
Irish biopharma company Jazz Pharmaceuticals has agreed to acquire British pharma company GW Pharmaceuticals in…
Bexson Biomedical raises $4.8m in Series A round for subcutaneous ketamine treatment platform
Bexson Biomedical has raised $4.8 million in a Series A financing round for developing a…
Horizon Therapeutics to acquire Viela Bio for $3bn to grow rare disease portfolio
Horizon Therapeutics, an Irish biopharma company, has agreed to acquire Viela Bio, a US-based biotech…
Nordic Capital offers to acquire Advanz Pharma for $846m
Nordic Capital has made an offer to acquire Advanz Pharma, a UK-based specialty pharma company,…
